Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hishiki

Showing results (361-370 of 399) with videos related to

Pageof 40
Sort By:
Cell Reports|January 6, 2021
OGT Regulates Hematopoietic Stem Cell Maintenance via PINK1-Dependent MitophagyKoichi Murakami, Daisuke Kurotaki, Wataru Kawase, et al.
Plos Pathogens|January 7, 2016
Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus ReplicationYouichi Suzuki, Wei-Xin Chin, Qi'En Han, et al.
Plos One|November 19, 2013
A critical role of fatty acid binding protein 4 and 5 (FABP4/5) in the systemic response to fastingMas Rizky A A Syamsunarno, Tatsuya Iso, Hirofumi Hanaoka, et al.
Circulation Research|October 10, 2009
Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heartJin Endo, Motoaki Sano, Takaharu Katayama, et al.
Journal of Diabetes Research|November 30, 2019
Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney DiseaseKazuo Kobayashi, Masao Toyoda, Noriko Kaneyama, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 17, 2023
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney diseaseShunichiro Tsukamoto, Kazuo Kobayashi, Masao Toyoda, et al.
The Lancet. Oncology|November 26, 2016
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International CollaborationRebecka L Meyers, Rudolf Maibach, Eiso Hiyama, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 31, 2018
Renal effects of sodium glucose co-transporter 2 inhibitors in Japanese type 2 diabetes mellitus patients with home blood pressure monitoringKazuo Kobayashi, Masao Toyoda, Moritsugu Kimura, et al.
Eclinicalmedicine|September 23, 2024
Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children's hepatic tumors international collaboration databaseEiso Hiyama, Tomoro Hishiki, Kenichi Yoshimura, et al.
Diabetes & Vascular Disease Research|October 5, 2018
Retrospective analysis of effects of sodium-glucose co-transporter 2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney diseaseKazuo Kobayashi, Masao Toyoda, Moritsugu Kimura, et al.
Pageof 40

Showing results (361-370 of 399) with videos related to

Sort By:
Pageof 40
Cell Reports|January 6, 2021
OGT Regulates Hematopoietic Stem Cell Maintenance via PINK1-Dependent MitophagyKoichi Murakami, Daisuke Kurotaki, Wataru Kawase, et al.
Plos Pathogens|January 7, 2016
Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus ReplicationYouichi Suzuki, Wei-Xin Chin, Qi'En Han, et al.
Plos One|November 19, 2013
A critical role of fatty acid binding protein 4 and 5 (FABP4/5) in the systemic response to fastingMas Rizky A A Syamsunarno, Tatsuya Iso, Hirofumi Hanaoka, et al.
Circulation Research|October 10, 2009
Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heartJin Endo, Motoaki Sano, Takaharu Katayama, et al.
Journal of Diabetes Research|November 30, 2019
Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney DiseaseKazuo Kobayashi, Masao Toyoda, Noriko Kaneyama, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 17, 2023
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney diseaseShunichiro Tsukamoto, Kazuo Kobayashi, Masao Toyoda, et al.
The Lancet. Oncology|November 26, 2016
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International CollaborationRebecka L Meyers, Rudolf Maibach, Eiso Hiyama, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 31, 2018
Renal effects of sodium glucose co-transporter 2 inhibitors in Japanese type 2 diabetes mellitus patients with home blood pressure monitoringKazuo Kobayashi, Masao Toyoda, Moritsugu Kimura, et al.
Eclinicalmedicine|September 23, 2024
Upfront or delayed surgery in resectable hepatoblastoma: analysis from the children's hepatic tumors international collaboration databaseEiso Hiyama, Tomoro Hishiki, Kenichi Yoshimura, et al.
Diabetes & Vascular Disease Research|October 5, 2018
Retrospective analysis of effects of sodium-glucose co-transporter 2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney diseaseKazuo Kobayashi, Masao Toyoda, Moritsugu Kimura, et al.
Pageof 40